Four novel ACE-inhibitory peptides were identified from rice-based distillers' spent cake hydrolysates, with IC50 values ranging from 11.63 to 33.54 μmol/L, and molecular docking revealed key binding interactions at both active and inactive sites of ACE.
IC50: 11.63 μmol/LThe most potent novel ACE-inhibitory peptide from rice distillery waste showed strong inhibitory activity, comparable to other food-derived bioactive peptides
What the researchers found
Four novel ACE-inhibitory peptides from RDSC hydrolysates showed IC50 values of 11.63, 12.34, 19.55, and 33.54 μmol/L. Molecular docking identified key residues (Glu123, Asp121, Arg522, Lys118) at both active and inactive ACE sites that enhance inhibitory activity.
Why it matters
ACE inhibitors are a cornerstone of hypertension treatment but synthetic versions can cause side effects like dry cough. Food-derived ACE-inhibitory peptides represent a potentially safer, natural alternative. Identifying potent peptides from industrial waste also adds value to agricultural byproducts.
The numbers in context
Alcalase hydrolysis for 4 hours was used. Multiple ACE-inhibitory peptides identified and characterized by molecular docking.
How the study worked
In vitro study: alcalase hydrolysis of RDSC for 4 hours, ultrafiltration to isolate low-molecular-weight fractions, followed by chromatographic purification and LC-MS/MS peptide identification. ACE inhibition measured in vitro. Molecular docking performed to analyze binding interactions.
Who was studied
Rice-based distillers' spent cake hydrolysates
What this study cannot tell us
Entirely in vitro — no evidence these peptides survive digestion, cross the intestinal barrier, or lower blood pressure in living organisms. IC50 values were measured in a test tube, which may not reflect in vivo potency. Molecular docking is computational prediction, not experimental proof of binding.
How to read the evidence
Rated preliminary: in vitro ACE inhibition and computational docking only. No in vivo or clinical evidence of blood pressure-lowering effects.
When this study was published
Published in 2024. Reflects current methods in bioactive peptide discovery from food sources.
The bigger picture
This study contributes to the growing field of food-derived bioactive peptides, demonstrating that industrial food waste can yield peptides with therapeutic potential. If these peptides survive gastrointestinal digestion and reach the bloodstream, they could serve as natural functional food ingredients for blood pressure management.
Questions still open
- Do these peptides survive gastrointestinal digestion and reach the bloodstream in active form?
- How do their in vitro IC50 values compare to established ACE inhibitor drugs?
- Could these peptides be incorporated into functional food products at effective concentrations?
Common questions
Can food-derived peptides really lower blood pressure?
What is ACE and why does inhibiting it matter?
Read the original research
Preparation, identification, and molecular docking of novel angiotensin-converting enzyme inhibitory peptides derived from rice-based distillers' spent cakes.
Journal of the science of food and agriculture, 104(11), 6506-6517
Citation
Su, Hanxing; Fan, Wenlai; Xu, Yan; Tang, Shaopei; Yue, Dehong; Liao, Zuyue. (2024). Preparation, identification, and molecular docking of novel angiotensin-converting enzyme inhibitory peptides derived from rice-based distillers' spent cakes.. Journal of the science of food and agriculture, 104(11), 6506-6517. https://doi.org/10.1002/jsfa.13474